个人简介
承担、参与课题
国家自然科学基金面上项目,81874104,泛素化降解ARHGAP10致卵巢癌顺铂耐药的分子机制研究,2019/01-2022/12,58万元,在研,参加
上海市科委西医引导项目,18411964100,卵巢癌类器官模型在卵巢癌个体化精准治疗的转化研究,2018/01-2021/12,20万元,在研,参加
同济大学中央高校基本科研业务费交叉项目,1516219014,中性粒细胞在卵巢癌腹腔种植转移过程中的分子机制研究,2017/09/-2019/08,20万元,结题,主持
上海市科委西医引导项目,16411971900,腹腔镜下盆腔自主神经子宫支阻断改善子宫腺肌症保守手术临床疗效的评估,2016/07-2019/06,10万元,结题,参加
国家自然科学基金面上项目,81172461,基质成纤维细胞与子宫肌瘤发病机理的相关性研究,2012/01-2015/12,57万元,已结题,参加
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Weihong Yang, Li Liu, Caixia Li, Ning Luo, Rong Chen, Li Li, Fudong Yu, Zhongping Cheng*. TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway, Cell Death Dis. 2018 Sep; 9(9): 908
Qi Liu, Weihong Yang, Ning Luo, Jie Liu, Yuliang Wu, Jinye Ding, Caixia Li, Zhongping Cheng*. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer, J Cancer, 2020 May 18;11(15):4413-4420
Weihong Yang, Zhongping Cheng*, Hong Dai, Changchun Long, Hailun Liu. Laparoscopic-based score assessment combined with multiple disciplinary team in management of recurrent ovarian cancer: a single-center prospective study for personalized surgical therapy, Medicine (Baltimore) 2017 Jul; 96(30): e7440
Yang W, Liu M, Liu L, Jiang C, Chen L, Qu X, Cheng Z*. Uterine-Sparing Laparoscopic Pelvic Plexus Ablation, Uterine Artery Occlusion, and Partial Adenomyomectomy for Adenomyosis, J Minim Invasive Gynecol. 2017 Sep - Oct;24(6):940-945.
W. Yang, Z. Cheng*, J. Yu, H. Yang, Z. Liu, Q. Ren, L. Xu, Multicentre study to evaluate the clinical effects of laparoscopic uterine artery occlusion in combination with myomectomy to treat symptomatic uterine leiomyomas, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016, 204: 9–15